Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 14, Issue 4, 2009, Pages 387-395

  Bussard, Karen M ^a   Mastro, Andrea M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bone metastasis; Bone microenvironment; Breast cancer; IL 6; MCP 1; Osteoblast; VEGF

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; MICROENVIRONMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STEREOMICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE NEOPLASMS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM TRANSPLANTATION;

EID: 75149153234     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-009-9159-z     Document Type: Article

References (45)

1. Society AC. Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.
2. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics 2009 CA Cancer J Clin 59 225 49 10.3322/caac.20006 19474385
3. Rubens RD, Mundy GR. Cancer and the skeleton. London: Martin Dunitz; 2000.
4. CS Galasko 1982 Mechanisms of lytic and blastic metastatic disease of bone Clin Orthop 169 20 7 7105580
5. TA Guise GR Mundy 1998 Cancer and bone Endocr Rev 19 18 54 10.1210/er.19.1.18 1:STN:280:DyaK1c7lsFyrsQ%3D%3D 9494779
6. GR Mundy 2002 Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 584 93 10.1038/nrc867 1:CAS:528: DC%2BD38XlslGqsLo%3D 12154351 (Pubitemid 37328925)
7. TJ Martin JM Moseley 2000 Mechanisms in the skeletal complications of breast cancer Endocr Rel Cancer 7 271 84 10.1677/erc.0.0070271 1:CAS:528:DC%2BD3MXisFymt7o%3D (Pubitemid 32172275)
8. JM Chirgwin TA Guise 2003 Cancer metastasis to bone Sci Med 9 140 51 1:CAS:528:DC%2BD2cXlsVGiug%3D%3D
9. R Cailleau M Olive QV Cruciger 1978 Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization In Vitro 14 911 5 10.1007/BF02616120 1:STN:280:DyaE1M%2FoslCqtQ%3D%3D 730202
10. T Yoneda A Sasaki GR Mundy 1994 Osteolytic bone metastasis in breast cancer Breast Cancer Res Treat 32 73 84 10.1007/BF00666208 1:STN:280: DyaK2M7hvFCiuw%3D%3D 7819589 (Pubitemid 24322250)
11. JE Price 1996 Metastasis from human breast cancer cell lines Breast Cancer Res Treat 39 93 102 10.1007/BF01806081 1:STN:280:DyaK28zislymsA%3D%3D 8738609 (Pubitemid 26136507)
12. PA Phadke KS Vaidya KT Nash DR Hurst DR Welch 2008 BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process Am J Pathol 172 809 17 10.2353/ajpath.2008. 070772 1:CAS:528:DC%2BD1cXktVKgsrY%3D 18276787 (Pubitemid 351354552)
13. Soule H, McGrath CM. Inventors; Immortal human mammary epithelial cell lines. United States patent 5,026,637. 1991.
14. MJ Siciliano PE Barker R Cailleau 1979 Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker Cancer Res 39 919 22 1:CAS:528:DyaE1MXhtlGqtr4%3D 427779
15. R Cailleau R Young M Olive WJ Reeves Jr 1974 Breast tumor cell lines from pleural effusions J Natl Cancer Inst 53 661 74 1:STN:280:DyaE2M%2FgslGkuw%3D%3D 4412247
16. T Yoneda 2000 Cellular and molecular basis of preferential metastasis of breast cancer to bone J Orthop Sci 5 75 81 10.1007/s007760050012 1:STN:280:DC%2BD3c7jtFSltQ%3D%3D 10664443
17. O Peyruchaud B Winding I Pecheur C-M Serre P Delmas P Clezardin 2001 Early detection of bone metastases in a murine model using fluorescent human breast cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions J Bone Miner Res 16 2027 34 10.1359/jbmr.2001.16.11.2027 1:CAS:528:DC%2BD3MXot12lsLg%3D 11697798
18. LM Kalikin A Schneider MA Thakur, et al. 2003 In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice Cancer Biol Ther 2 656 60 14688471
19. Y-X Sun A Schneider Y Jung, et al. 2004 Skeletal localization and neutralization of the SDF-1 (CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo J Bone Min Res 20 318 29 10.1359/JBMR.041109
20. Y Kang PM Siegel W Shu, et al. 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Res 3 537 49 1:CAS:528:DC%2BD3sXltlSmsL4%3D
21. T Yoneda PJ Williams T Hiraga M Niewolna R Nishimura 2001 A bone-seeking clone exhibits different biological properties from the MDA-MD-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro J Bone Miner Res 16 1486 95 10.1359/jbmr.2001.16.8.1486 1:CAS:528:DC%2BD3MXmtVOhur8%3D 11499871
22. JE Talmadge RK Singh IJ Fidler A Raz 2007 Murine models to evaluate novel and conventional therapeutic strategies for cancer Am J Pathol 170 793 804 10.2353/ajpath.2007.060929 1:CAS:528:DC%2BD2sXjs1Wls78%3D 17322365 (Pubitemid 47339349)
23. PA Phadke RR Mercer JF Harms, et al. 2006 Kinetics of metastatic breast cancer cell trafficking in bone Clin Cancer Res 12 1431 40 10.1158/1078-0432. CCR-05-1806 16533765
24. DG DeNardo LM Coussens 2007 Inflammation and breast cancer. Balancing immune response: crosstalk between adapative and innate immune cells during breast cancer progression Breast Cancer Res 9 212 10.1186/bcr1746 17705880
25. DG DeNardo M Johansson LM Coussens 2008 Immune cells as mediators of solid tumor metastasis Cancer Metastasis Rev 27 11 8 10.1007/s10555-007-9100-0 1:CAS:528:DC%2BD1cXhtV2gurc%3D 18066650
26. M Wick P Dubey H Koeppen, et al. 1997 Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion of systemic anergy J Exp Med 186 229 38 10.1084/jem.186.2.229 1:CAS:528:DyaK2sXkvVaksLg%3D 9221752 (Pubitemid 27328023)
27. VIF Slettenaar JL Wilson 2006 The chemokine network: a target in cancer biology? Adv Drug Deliv Rev 58 962 74 10.1016/j.addr.2006.03.012 1:CAS:528:DC%2BD28Xht1Sht7bL 16996642 (Pubitemid 44780906)
28. Fitzgerald KA, O'Neill LAJ, Gearing AJH, Callard RE. The cytokine facts book. 2nd ed. San Diego: Academic; 2001.
29. EF de Zoeten V Carr-Brendel EP Cohen 1998 Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfeced with DNA from mouse melanona cells J Immunol 160 2915 22 9510195
30. S Braun C Thioudellet P Rodriguez, et al. 2000 Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice Gene Ther 7 1447 57 10.1038/sj.gt.3301261 1:CAS:528:DC%2BD3cXmsVyitL4%3D 11001364
31. C Kuperwasser S Dessain BE Bierbaum, et al. 2005 A mouse model of human breast cancer metastasis to human bone Cancer Res 65 6130 8 10.1158/0008-5472. CAN-04-1408 1:CAS:528:DC%2BD2MXmt1ehurk%3D 16024614 (Pubitemid 40994398)
32. CJ Aslakson FR Miller 1992 Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res 52 1399 405 1:STN:280:DyaK387nsVWmsA%3D%3D 1540948
33. M Lelekakis JM Moseley TJ Martin, et al. 1999 A novel orthotopic model of breast cancer metastasis to bone Clin Exp Metastasis 17 163 70 10.1023/A:1006689719505 1:STN:280:DyaK1Mzjs1yqsg%3D%3D 10411109 (Pubitemid 29335443)
34. PB Gupta C Kuperwasser 2004 Disease models of breast cancer Drug Discov Today 1 9 16 1:CAS:528:DC%2BD2cXhtVegtbvN
35. CT Guy MA Webster M Schaller TJ Parsons RD Cardiff WJ Muller 1992 Expression of the neu protoncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Aca Sci USA 89 10578 82 10.1073/pnas.89.22.10578 1:CAS:528:DyaK3sXjs1ymsw%3D%3D
36. PM Siegel W Shu RD Cardiff WJ Muller J Massague 2003 Transforming growth factor β signaling impairs neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc Natl Aca Sci USA 100 8430 5 10.1073/pnas.0932636100 1:CAS:528:DC%2BD3sXlsFGntLc%3D (Pubitemid 36842562)
37. TA Guise 2000 Molecular mechanisms of osteolytic bone metastases Cancer 88 2892 8 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y 1:CAS:528:DC%2BD3cXksVCms7k%3D 10898330
38. M Bendre DC Montague T Peery NS Akel D Gaddy LJ Suva 2003 Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease Bone 33 28 37 10.1016/S8756-3282(03)00086-3 1:CAS:528:DC%2BD3sXmt1KjsLw%3D 12919697 (Pubitemid 36952685)
39. M Bendre D Gaddy RW Nicholas LJ Suva 2003 Breast cancer metastasis to bone Clin Orthop Relat Res 415S S39 45 10.1097/01.blo.0000093844.72468.f4
40. M Bendre D Gaddy-Kurten T Foote-Mon, et al. 2002 Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo Cancer Res 62 5571 9 1:CAS:528:DC%2BD38Xnsl2lsbo%3D 12359770
41. AM Mastro CV Gay DR Welch, et al. 2004 Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation J Cell Biochem 91 265 76 10.1002/jcb.10746 1:CAS:528:DC%2BD2cXhsVSqur4%3D 14743387
42. R Mercer C Miyasaka AM Mastro 2004 Metastatic breast cancer cells suppress osteoblast adhesion and differentiation Clin Exp Metastasis 21 427 35 10.1007/s10585-004-1867-6 1:CAS:528:DC%2BD2MXht1Khsrk%3D 15672867
43. R Mercer AM Mastro 2005 Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K Exp Cell Res 310 270 81 10.1016/j.yexcr. 2005.07.029 1:CAS:528:DC%2BD2MXhtFeku7nL 16154565 (Pubitemid 41457332)
44. M Kinder EM Chislock KM Bussard LA Shuman AM Mastro 2008 Metastatic breast cancer induces an osteoblast inflammatory response Exp Cell Res 314 173 83 10.1016/j.yexcr.2007.09.021 1:CAS:528:DC%2BD2sXhtlyrtrvE 17976581 (Pubitemid 350182446)
45. JF Harms LR Budgeon ND Christensen DR Welch 2002 Maintaining GFP tissue fluorescence through bone decalcification and long-term storage BioTechniques 33 1197 200 1:CAS:528:DC%2BD38Xps1enu74%3D 12503297